Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Frataxin pseudogene 2 (FXNP2)
- Target
- FXNP2
- Molecular classification
- Other (pseudogene)
01
Overview
Frataxin pseudogene 2 (FXNP2) is a genomic sequence similar to the functional frataxin (FXN) gene but is classified as a pseudogene, meaning it does not code for a functional protein product and does not play an established biological or pathological role. It should not be confused with the functional FXN gene, which encodes the mitochondrial protein frataxin—a critical participant in mitochondrial iron regulation, iron-sulfur cluster assembly, and tightly linked to Friedreich ataxia if mutated or dysregulated[1][2][3][4]. There are no known therapeutic roles, biomarkers, or drugs acting on FXNP2 itself.
- Other names
- FXNP2frataxin pseudogene 2FXN-pseudogene 2
Beyond the preview
Go deeper on Frataxin pseudogene 2 (FXNP2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Frataxin pseudogene 2 (FXNP2).